Navigation Links
Crisalix Awarded as a Leading Life Science Company that is Revolutionizing the Medical Industry

Lausanne, Switzerland (PRWEB) December 12, 2012

Crisalix, amongst “the best-of-the-best at the 2012 European Venture Contest” [Europe Unlimited]

The European Venture Contest (EVC) held in Berlin is the largest meeting point for innovative entrepreneurs in the Information & Communications Technology (ICT), Life Sciences and Cleantech sectors. The EVC plays an important role in finding, evaluating and recognizing world-class innovative companies to accelerate their growth by providing access to top-level international partners, and supporting these global leaders of tomorrow by updating the skill set needed to grow their business successfully.

The EVC brings together over 300 top tier venture investors as well as corporate investors from multinationals such as IBM, Roche, Microsoft, Philips, SAP and more. Through 10 rounds of presentations and shortlisting which took place over one year across the main European countries, from an initial 800+ companies the jury made a final selection of the top 10 companies which included Crisalix as one of the only three Life Science companies offering novel technologies, products and services that are expected to dramatically impact their respective industry over the coming years.

This award from top international investors based on specific criteria related to business potential, product merit, competitive positioning and project profile quality amongst others, confirms Crisalix’s position as a leader and pioneer in the field of Aesthetics. It is recognition for the potential that Crisalix represents today and for the years ahead.

About Crisalix

If you were considering modifying your physical appearance, wouldn’t you be wondering “how could I look after the procedure?” Crisalix is a worldwide leader in easy 3D aesthetic simulations based on standard digital photos which provides an answer to the first and foremost question every aesthetic patient asks their physician. With the first cloud solution and SaaS business model for 3D simulations of aesthetic procedures and plastic surgery, Crisalix brings together the latest advancements in surgical and aesthetic technology, 3D and information technology. Crisalix has already enabled physicians in over 70 countries to increase the care and treatment provided to their patients thanks to its unique 3D simulation technology based on regular 2D photos.

Crisalix has been recommended by The International Confederation for Plastic, Reconstructive, and Aesthetic Surgery (IPRAS) for its contribution to improving the care and treatment of patients around the world seeking aesthetic procedures.

Further information

Patients interested in breast augmentation or aesthetic procedures should schedule a consultation by finding the nearest physician offering Crisalix simulations using the Aesthetic Professional Directory.

Physicians interested in incorporating Crisalix 3D simulations in their aesthetic consultations should directly open an account on:

Press contacts: Nandan Sampatkumar
Tel: (00 41) 21 693 90 01
Email: press(at)crisalix(dot)com

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Plant Sensory Systems Awarded $1.8 Million from ARPA-E to Engineer Beets for Biofuel
2. Ben-Gurion University awarded $6.5 million grant to develop nano thin infrared night vision glasses
3. Arecor Awarded Biomedical Catalyst Funding Towards £1.3 Million Project
4. WaferGen Bio-systems Awarded 1 Million Euro Grant by the Luxembourg Government to expand its European Operations
5. Stanford faculty awarded $2.2 million for innovative energy research
6. CSL Biotherapies Awarded US Government Contract for Influenza Pandemic Preparedness and Response
7. Avery-Landsteiner Prize for Immunology Awarded to Alain Fischer of Paris, France, by German Society for Immunology
8. Trellis Bioscience Awarded SBIR Grant to Advance CMV Program
9. Astrix Technology Group Awarded Department of Homeland Security BioWatch Laboratory Staffing Contract
10. Ekahau - A Preferred Provider of Real-Time Location Solutions - Is Awarded an Agreement with the Premier Healthcare Alliance
11. Elusys Awarded Additional $50.2 Million Under An Exisiting U.S. Government Contract To Support Final Stages Of Development Of ETI-204, For Treatment Of Inhalational Anthrax
Post Your Comments:
(Date:11/25/2015)... -- Studies reveal the differences in species ... the way for more effective treatment for one of the ... --> --> Gum disease ... cats, yet relatively little was understood about the bacteria associated ... conducted by researchers from the WALTHAM Centre for Pet Nutrition ...
(Date:11/25/2015)... Nov. 25, 2015 Orexigen® Therapeutics, Inc. (Nasdaq: ... in a fireside chat discussion at the Piper Jaffray ... . The discussion is scheduled for Wednesday, December ... .  A replay will be available for 14 ... , Julie NormartVP, Corporate Communications and Business Development ...
(Date:11/24/2015)... Nov. 24, 2015 Cepheid (NASDAQ: CPHD ... at the following conference, and invited investors to participate ...      Tuesday, December 1, 2015 at 11.00 a.m. ...      Tuesday, December 1, 2015 at 11.00 a.m. ... New York, NY      Tuesday, December ...
(Date:11/24/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: AEZ) ... of the Toronto Stock Exchange, confirms that as of ... corporate developments that would cause the recent movements in ... --> About Aeterna Zentaris Inc. ... Aeterna Zentaris is a specialty biopharmaceutical company engaged ...
Breaking Biology Technology:
(Date:11/2/2015)... 2015  SRI International has been awarded a contract ... services to the National Cancer Institute (NCI) PREVENT Cancer ... expertise, modern testing and support facilities, and analytical instrumentation ... toxicology studies to evaluate potential cancer prevention drugs. ... Cancer Drug Development Program is an NCI-supported pipeline to ...
(Date:10/29/2015)... 2015  Connected health pioneer, Joseph C. Kvedar ... technology-enabled health and wellness, and the business opportunities that ... The Internet of Healthy Things . Long before ... existed, Dr. Kvedar, vice president, Connected Health, Partners HealthCare, ... moving care from the hospital or doctor,s office into ...
(Date:10/27/2015)... Oct. 27, 2015 Synaptics Inc. (NASDAQ: SYNA ... that Google has adopted the Synaptics ® ClearPad ... to power its newest flagship smartphones, the Nexus 5X ... --> --> Synaptics ... provide strategic collaboration in the joint development of next ...
Breaking Biology News(10 mins):